A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis

Clinical trial NCT05604261 · UNKNOWN

Trial details

NCT number: NCT05604261
Sponsor: Xuanzhu Biopharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Reflux Esophagitis Gastroesophageal Reflux Esophagitis Esophageal Motility Disorders Deglutition Disorders Esophageal Diseases Gastrointestinal Diseases

Start date: 2022-12-01
Primary completion: 2023-07-01
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.